Of interest, miR-375-3p, miR-210-3p and let-7e have shown discrepancies regarding the clinical significance as prognostic biomarkers [16,17,18,19,20], being reported to have both increased and decreased expression associations with BC patients’ response to NAT. This evidence concerns the gene BRD2 and breast cancer.